Demonstration of Inhibition of Mediator Release From Human Mast Cells by Azatadine Base: In Vivo and In Vitro Evaluation

JAMA: The Journal of the American Medical Association

Volumn 255, Issue 2, 1986, Pages 225-229

  Togias, Alkis G ^a   Naclerio, Robert M ^a   Warner, Jane ^a   Proud, David ^a   Kagey Sobotka, Anne ^a   Nimmagadda, Indira ^a   Norman, Philip S ^a   Lichtenstein, Lawrence M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIHISTAMINIC AGENT; AZATADINE; HISTAMINE; LEUKOTRIENE C4;

CLINICAL ARTICLE; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION; INTRANASAL DRUG ADMINISTRATION; MAST CELL; NOSE MUCOSA; OLFACTORY SYSTEM; PREVENTION; PRIORITY JOURNAL; THERAPY;

ADOLESCENT; ADULT; CLINICAL TRIALS; CYPROHEPTADINE; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; HUMANS; KININS; LUNG; MALE; MAST CELLS; MIDDLE AGED; NASAL PROVOCATION TESTS; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; RHINITIS, ALLERGIC, SEASONAL; SRS-A;

EID: 84944283039     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1986.03370020071030     Document Type: Article

References (14)

1. Lichtenstein LM, Gillespie E: The effects of the H, and H2 antihistamines on ‘allergic’ histamine release and its inhibition by histamine. J Pharmacol Exp Ther 1975;192:441-450.
2. Schulman ES, MacGlashan DW, Peters SP, et al.: Human lung mast cells: Purification and characterization. J Immunol 1982;129:2062-2067.
3. Naclerio RM, Meier HL, Kagey-Sobotka A, et al.: Mediator release after nasal challenge with allergen. Am Rev Respir Dis 1983;128:597-602.
4. Proud D, Togias A, Naclerio RM, et al.: Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983;79:1678-1685.
5. Creticos PS, Peters SP, Adkinson NF Jr, et al.: Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 1984;310:1626-1630.
6. Naclerio RM, Meier HL, Kagey-Sobotka A, et al.: In Vivo model for the evaluation of topical antiallergic medications. Arch Otolaryngol 1984; 110:25-27.
7. Siraganian R: An automated continuous flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 1974;57:283-284.
8. Imanari T, Kaizu T, Yoshida H, et al.: Radiochemical assays for human urinary, salivary and plasma kallikreins, in Pisano JJ, Austen KF (eds): Chemistry and Biology of Kallikrein-Kinin System in Health and Disease, publication (NIH) 76-791. Dept of Health, Education, and Welfare, 1976, pp 205-213.
9. Hayes EC, Lombardo DL, Girard Y, et al.: Measuring leukotrienes of slow reacting substances of anaphylaxis: Development of a specific radioimmunoassay. J Immunol 1983;131:429-433.
10. Peters SP, MacGlashan DW Jr, Schulman ES, et al.: The production of arachidonic acid (AA) metabolites by purified human lung mast cells (HMC). Fed Proc 1983;42:1375.
11. Plaut M, Lichtenstein LM (eds): Cellular and chemical basis of the allergic inflammatory response, in Middleton E Jr, Reed CE, Ellis EF (eds): Allergy: Principles and Practice. St Louis, CV Mosby Co, pp 119-146.
12. Proud D, Schulman ES, MacGlashan DW Jr, et al.: Anaphylactic release of a kininogenase from purified human lung mast cells, abstracted. Clin Res 1982;30:165A.
13. Schwartz LB, Lewis RA, Austen KF: Tryptase from human pulmonary mast cells: Purification and characterization. J Biol Chem 1981; 256:11939-11943.
14. Rumore MM, Schlichting DA: Analgesic effects of antihistaminics. Life Sci 1985;36:403-416.